Skip to main content

Table 1 Participant demographic and clinical characteristics at enrolment

From: Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya

 

Total enrolled (n = 169)

Age; median (IQR)

23 (5–36)

Male; n (%)

75 (44)

Febrile subjects (37.5); n (%)

33 (19.8)

Duration of fever (days); median (IQR)

3 (2–3)

Having chronic conditions; n (%)

13 (7.7)

Took antimalarials in the last one month; n (%)

13 (7.7)

Travelled in the last 3 months; n (%)

13 (7.7)

Slept under a bed net in previous night; n (%)

155 (91.7)

Covered by IRS programme for the last one year; n (%)

119 (70.4)

Enrolled in RTS,S vaccine trial; n (%)

3 (1.9)

Pregnancy; n (% of total female)

4 (2.4)

Haematological parameters*

White blood cell (103/μL); median (IQR)

5.93 (4.82–8.93)

Red blood cell (106/μL); median (IQR)

5.04 (4.67–5.46)

Haemoglobin (g/dL); median (IQR)

13.1 (11.5–14.2)

Anaemia (Hb < 11 g/dL); n (%)

34 (20.1)

Haematocrit (%); median (IQR)

39.8 (34.6–43.1)

Platelets (103/μL); median (IQR)

256 (197–364)

Thrombocytopenia (< 150 × 103/μL); n (%)

14 (8.3)

  1. *Measured with venous blood in LM mode on the XN-31p